Search Results - "Alonso, Maria Luisa Manzano"

Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy by Maria Luisa Manzano-Alonso Gregorio Castellano-Tortajada

“…Reactivation of hepatitis B is defined as the recurrence or an abrupt rise in hepatitis B virus（HBV） replication,often accompanied by an increase in serum…”
Get full text

Spontaneous clearance of chronic hepatitis C in an immunocompetent patient by López Couceiro, Laura, Manzano Alonso, María Luisa, Fernández Vázquez, Inmaculada

“…Spontaneous clearance of chronic hepatitis C virus (HCV) infection is rare and the cases described have been mainly in immunosuppressed patients (HIV). For…”
Get full text

THU-381 Prognostic implications of liver stiffness impairment after HCV cure in cACLD patients by Pons, Monica, Semmler, Georg, Lopez, Sonia Alonso, Lens, Sabela, Dajti, Elton, Griemsmann, Marie, Zanetto, Alberto, Burghart, Lukas, Hametner-Schreil, Stephanie, Hartl, Lukas, Alonso, Maria Luisa Manzano, Rodriguez-Tajes, Sergio, Zanaga, Paola, Schwarz, Michael, Gutierrez, Maria Luisa, Jachs, Mathias, Pocurull, Anna, Lorduy, Benjamin Polo, Ecker, Dominik, Muñoz, Beatriz Mateos, Izquierdo, Sonia, Martínez, Yolanda Real, Gschwantler, Michael, Russo, Francesco Paolo, Azzaroli, Francesco, Maasoumy, Benjamin, Reiberger, Thomas, Forns, Xavier, Bañares, Rafael, Mandorfer, Mattias, Genesca, Joan

Get full text

The risks of first hepatic decompensation and HCC remain constant during long-term follow-up and can be stratified by a one-time assessment after HCV-cure by Semmler, Georg, Lopez, Sonia Alonso, Pons, Monica, Lens, Sabela, Dajti, Elton, Griemsmann, Marie, Zanetto, Alberto, Burghart, Lukas, Hametner-Schreil, Stephanie, Hartl, Lukas, Ahumada, Adriana, Rodriguez-Tajes, Sergio, Zanaga, Paola, Schwarz, Michael, Uson, Clara, Jachs, Mathias, Pocurull, Anna, Manzano Alonso, Maria Luisa, Ecker, Dominik, Riado, Daniel, Muñoz, Beatriz Mateos, Gschwantler, Michael, Russo, Francesco Paolo, Azzaroli, Francesco, Maasoumy, Benjamin, Reiberger, Thomas, Forns, Xavier, Genesca, Joan, Bañares, Rafael, Mandorfer, Mattias

Get full text

Validation and refinement of the Baveno VII criteria for risk stratification in compensated advanced chronic liver disease after HCV-cure by Semmler, Georg, Lopez, Sonia Alonso, Pons, Monica, Lens, Sabela, Dajti, Elton, Griemsmann, Marie, Zanetto, Alberto, Burghart, Lukas, Hametner-Schreil, Stephanie, Hartl, Lukas, Ahumada, Adriana, Rodriguez-Tajes, Sergio, Zanaga, Paola, Schwarz, Michael, Uson, Clara, Jachs, Mathias, Pocurull, Anna, Manzano Alonso, Maria Luisa, Ecker, Dominik, Riado, Daniel, Muñoz, Beatriz Mateos, Gschwantler, Michael, Russo, Francesco Paolo, Azzaroli, Francesco, Maasoumy, Benjamin, Reiberger, Thomas, Forns, Xavier, Genesca, Joan, Bañares, Rafael, Mandorfer, Mattias

Get full text

OS-127-YI - The risks of first hepatic decompensation and HCC remain constant during long-term follow-up and can be stratified by a one-time assessment after HCV-cure by Semmler, Georg, Lopez, Sonia Alonso, Pons, Monica, Lens, Sabela, Dajti, Elton, Griemsmann, Marie, Zanetto, Alberto, Burghart, Lukas, Hametner-Schreil, Stephanie, Hartl, Lukas, Ahumada, Adriana, Rodriguez-Tajes, Sergio, Zanaga, Paola, Schwarz, Michael, Uson, Clara, Jachs, Mathias, Pocurull, Anna, Manzano Alonso, Maria Luisa, Ecker, Dominik, Riado, Daniel, Muñoz, Beatriz Mateos, Gschwantler, Michael, Russo, Francesco Paolo, Azzaroli, Francesco, Maasoumy, Benjamin, Reiberger, Thomas, Forns, Xavier, Genesca, Joan, Bañares, Rafael, Mandorfer, Mattias

Get full text

SAT-521 - Validation and refinement of the Baveno VII criteria for risk stratification in compensated advanced chronic liver disease after HCV-cure by Semmler, Georg, Lopez, Sonia Alonso, Pons, Monica, Lens, Sabela, Dajti, Elton, Griemsmann, Marie, Zanetto, Alberto, Burghart, Lukas, Hametner-Schreil, Stephanie, Hartl, Lukas, Ahumada, Adriana, Rodriguez-Tajes, Sergio, Zanaga, Paola, Schwarz, Michael, Uson, Clara, Jachs, Mathias, Pocurull, Anna, Manzano Alonso, Maria Luisa, Ecker, Dominik, Riado, Daniel, Muñoz, Beatriz Mateos, Gschwantler, Michael, Russo, Francesco Paolo, Azzaroli, Francesco, Maasoumy, Benjamin, Reiberger, Thomas, Forns, Xavier, Genesca, Joan, Bañares, Rafael, Mandorfer, Mattias

Get full text

Healthcare resource utilization in treatment-naïve patients with compensated cirrhosis receiving 8-weeks’ glecaprevir/ pibrentasvir stratified by drug use and socioeconomic status: a retrospective chart review by Uriz Otano, Juan Isidro, Abergel, Armand, Aghemo, Alessio, Ahumada, Adriana, Andreoni, Massimo, Asselah, Tarik, Bhagat, Abhi, Butrymowicz, Isabel, Conway, Brian, Gasbarrini, Antonio, Jorquera, Francisco, Lampertico, Pietro, Manzano Alonso, Maria Luisa, Myles, Lindsy, Persico, Marcello, Ramji, Alnoor, Semizarov, Dimitri, Song, Yanna, Villa, Erica, Xu, Qingqing

Get full text

Eight-weeks of glecaprevir/pibrentasvir is well tolerated and yields high sustained virological response in HCV-infected treatment-naive patients with compensated cirrhosis: the CREST study by Cornberg, Markus, Abergel, Armand, Aghemo, Alessio, Ahumada, Adriana, Andreoni, Massimo, Asselah, Tarik, Bhagat, Abhi, Butrymowicz, Isabel, Carmiel, Michal, Chodik, Gabriel, Conway, Brian, Gasbarrini, Antonio, Hüppe, Dietrich, Jorquera, Francisco, Lampertico, Pietro, Manzano Alonso, Maria Luisa, Myles, Lindsy, Persico, Marcello, Ramji, Alnoor, Sarrazin, Christoph, Semizarov, Dimitri, Song, Yanna, Villa, Erica, Weil, Clara, Uriz Otano, Juan Isidro

Get full text

FRI-012-Analysis of clinical and histological factors to differentiate autoimmune hepatitis of drug induced liver injury by Campo, Lidia Cuevas del, Gómez-Domínguez, Elena, Gil, Yolanda Rodriguez, Alonso, Maria Luisa Manzano, Algibez, Ana Martin, Tortajada, Gregorio Castellano, Vázquez, Inmaculada Fernández

Get full text

Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study by Cornberg, Markus, Ahumada, Adriana, Aghemo, Alessio, Andreoni, Massimo, Bhagat, Abhi, Butrymowicz, Isabel, Carmiel, Michal, Chodick, Gabriel, Conway, Brian, Song, Yanna, Gasbarrini, Antonio, Hüppe, Dietrich, Plaza, Francisco Jorquera, Lampertico, Pietro, Alonso, Maria Luisa Manzano, Myles, Lindsay, Persico, Marcello, Ramji, Alnoor, Sarrazin, Christoph, Villa, Erica, Weil, Clara, Otano, Juan Isidro Uriz

“…Introduction In clinical trials with hepatitis C virus-infected treatment-naïve (TN) patients with compensated cirrhosis (CC), glecaprevir/pibrentasvir (G/P),…”
Get full text

WED-372 - Effectiveness and safety of anticoagulant treatment in patients with liver cirrhosis and non-tumoral splenic-portal thrombosis by Salazar Parada, Nelson Daniel, Domínguez, Elena Gómez, Royo, Sara Pastor, Del Val Huerta, Nuria, Algibez, Ana Martín, Manzano Alonso, María Luisa, Amo, Maria, De las Heras, Berta, Vázquez, Inmaculada Fernández

Get full text

Effectiveness and safety of anticoagulant treatment in patients with liver cirrhosis and non-tumoral splenic-portal thrombosis by Salazar Parada, Nelson Daniel, Domínguez, Elena Gómez, Royo, Sara Pastor, Del Val Huerta, Nuria, Algibez, Ana Martín, Manzano Alonso, María Luisa, Amo, Maria, De las Heras, Berta, Vázquez, Inmaculada Fernández

Get full text

Hepatitis B virus in patients with chronic hepatitis C treated with direct antiviral agents by Gutiérrez García, María Luisa, Manzano Alonso, María Luisa, Ferrer Rosique, Juan Ángel, Muñoz Gómez, Raquel, Alonso López, Sonia, Fernández Álvarez, Inmaculada, Fernández Rodríguez, Conrado M

“…cases of hepatitis B virus (HBV) reactivation have been reported in patients with hepatitis C virus (HCV) treated with direct antiviral agents (DAA). the main…”
Get full text

Acute pancreatitis as the form of presentation of inflammatory bowel disease by Muñoz Codoceo, Carolina, Manzano Alonso, María Luisa, Solís Herruzo, José Antonio

Get more information